Sterling Capital Management LLC Viking Therapeutics, Inc. Transaction History
Sterling Capital Management LLC
- $7.74 Trillion
- Q3 2024
A detailed history of Sterling Capital Management LLC transactions in Viking Therapeutics, Inc. stock. As of the latest transaction made, Sterling Capital Management LLC holds 40,363 shares of VKTX stock, worth $2.22 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
40,363Holding current value
$2.22 Million% of portfolio
0.03%Shares
1 transactions
Others Institutions Holding VKTX
# of Institutions
479Shares Held
66.3MCall Options Held
5.9MPut Options Held
2.96M-
Vanguard Group Inc Valley Forge, PA10.2MShares$560 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.03MShares$332 Million0.01% of portfolio
-
State Street Corp Boston, MA4.67MShares$257 Million0.01% of portfolio
-
Jpmorgan Chase & CO New York, NY2.12MShares$117 Million0.01% of portfolio
-
Morgan Stanley New York, NY1.87MShares$103 Million0.01% of portfolio
About Viking Therapeutics, Inc.
- Ticker VKTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,688,496
- Market Cap $4.22B
- Description
- Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...